The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 Presidents Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 Presidents Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Trial Academy Master Class 6.0
    • The Business Of Law
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Chicago Probing Opioid Marketing, Considering Potential Legal Action

Posted on November 18, 2013 by Andrew Findley

News Inferno; November 15, 2013

Lawyers for the city of Chicago are looking into marketing claims made by the makers of some narcotic painkillers in advance of a potential lawsuit against the drug makers.

The probe concerns if the drug maker overstated the medications’ benefits while downplaying risks, including that patients could become addicted to the drugs known as opioids, a court filing indicates, according to The New York Times.

To read the complete article, please click here: http://www.newsinferno.com/chicago-probing-opioid-marketing-considering-potential-legal-action/

Posted in Blog, Newsletter

Comments are closed.

Recent Posts

Burlington Employees Receive $11M Settlement

Burlington Employees Receive $11M Settlement

October 5th, 2022

Discount retailer Burlington Stores, formerly known as Burlington Coat Factory, has agreed to an $11 million settlement in a[Read More...]
Negligence Lawsuit Filed for Murder of TikToker

Negligence Lawsuit Filed for Murder of TikToker

October 5th, 2022

A lawsuit has been filed in the murder of a woman in Streeterville in July who went viral on TikTok as she do[Read More...]
Ex-School Counselor Wins $12M in Damages

Ex-School Counselor Wins $12M in Damages

October 3rd, 2022

Donald Clark won $12 million in a lawsuit he filed against the state of Iowa on Thursday, years after being exonerated and r[Read More...]
Former NFL Player Wins $28M Over Surgery

Former NFL Player Wins $28M Over Surgery

October 3rd, 2022

A former NFL player has won a nearly $30 million verdict against a doctor who recently passed who he accused of me[Read More...]
Geico Workers Allege Tactics to Prevent Union

Geico Workers Allege Tactics to Prevent Union

September 30th, 2022

Workers at an office of US insurance giant Geico have embarked on a unionization campaign in the face of what they say are a[Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.